Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001871957 | SCV002275487 | uncertain significance | not provided | 2021-04-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CNGA3 protein function. This variant has been observed in individual(s) with clinical features of CNGA3-related conditions (Invitae). This variant is present in population databases (rs757650055, ExAC 0.001%). This sequence change replaces tryptophan with cysteine at codon 203 of the CNGA3 protein (p.Trp203Cys). The tryptophan residue is highly conserved and there is a large physicochemical difference between tryptophan and cysteine. |
Molecular Genetics Laboratory, |
RCV001729889 | SCV001571275 | uncertain significance | Achromatopsia 2 | 2021-04-15 | no assertion criteria provided | research |